MetaCap

Blue Water Acquisition III Unit. (BLUWU) vs Silexion Therapeutics (SLXN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Relative performance

BLUWU-0.76%SLXN+1173.66%
+1234%+567%-100%
Oct 7, 20261 yearNov 11, 2026
BLUWU-0.76%SLXN+822.65%
+865%+395%-75%
Oct 5, 20265 yearsNov 9, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BLUWU versus SLXN key metrics
MetricBLUWUSLXN
Share price$10.42$1.31
Market cap—$850.88K
1-day change0.00%-12.67%
YTD return-1.23%—
EPS (TTM)—$-2,437.44
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$4.67M$-11.91M
52-week high$12.85$777.12
52-week low$0.00$1.26
Distance from 52-week high-18.91%-99.83%
Analyst consensus—none
Avg. price target upside—+281.68%
Average volume45431.20K
Shares outstanding—649.53K
Employees—13
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Blue Water Acquisition III Unit.

BLUWU stock →

Blue Water Acquisition Corp. III does not have significant operations.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances)

About Silexion Therapeutics

SLXN stock →

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 13 employees

BLUWU vs SLXN FAQ

Are Blue Water Acquisition III Unit. and Silexion Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons